The most common significant DEG module across patient groups and DEG patient groups is module 11, with its dominant SGA EGFR. EGFR has been used as the primary marker in distinguishing between GBM patients and it was found to interact with multiple signalling pathways in GBM47. The gene discussed is EGFR; the disease is glioblastoma.